Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration

ClinicalTrials.gov ID: NCT00211536

Public ClinicalTrials.gov record NCT00211536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Active Control, Multi-Center Study Comparing the Effect of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration on Glycemic Control and the Frequency of Severe Hypoglycemia

Study identification

NCT ID
NCT00211536
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medtronic MiniMed, Inc.
Industry
Enrollment
107 participants

Conditions and interventions

Interventions

  • Medtronic MiniMed Implantable Pump Human Recombinant Insulin Drug
  • Medtronic MiniMed Implantable Pump System Device
  • Aventis HOE21PH U400 Drug

Drug · Device

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Jul 31, 2004
Completion
Aug 31, 2008
Last update posted
Sep 20, 2011

2002 – 2008

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Sansum Medical Research Institute Santa Barbara California 93105
University of Colorado Health Sciences Center Aurora Colorado 80010
Hellman & Rosen Endocrine Associates North Kansas City Missouri 64116
Cleveland Clinic Wooser Ohio 44195
Diabetes & Glandular Disease Clinic San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00211536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2011 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00211536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →